LivaNova PLC (LIVN)
USD 37.48
(-5.11%)
USD 37.48
(-5.11%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 39.01 Million USD | 44.62% |
| 2022 | 30.85 Million USD | 64.93% |
| 2021 | -6.33 Million USD | 74.03% |
| 2020 | -225.86 Million USD | -70.61% |
| 2019 | -87.7 Million USD | -16.13% |
| 2018 | -167.74 Million USD | -26.08% |
| 2017 | 199.26 Million USD | -13.33% |
| 2016 | 99.38 Million USD | 115.2% |
| 2015 | -25.9 Million USD | 21.89% |
| 2014 | 92.94 Million USD | 16.13% |
| 2013 | 93.08 Million USD | 30.62% |
| 2012 | 82.98 Million USD | 23.9% |
| 2011 | 65.64 Million USD | 33.81% |
| 2010 | 52.35 Million USD | 64.94% |
| 2009 | 22.4 Million USD | 678.62% |
| 2008 | 33.02 Million USD | 91.34% |
| 2007 | -2.31 Million USD | 18.41% |
| 2006 | -41.87 Million USD | -508.82% |
| 2005 | -52.59 Million USD | -180.23% |
| 2004 | -14.86 Million USD | 21.57% |
| 2003 | 11.61 Million USD | 140.11% |
| 2002 | 9.8 Million USD | 0.0% |
| 2000 | -3.75 Million USD | 70.42% |
| 1999 | -3.8 Million USD | 27.43% |
| 1998 | -12.6 Million USD | -54.87% |
| 1997 | -15.5 Million USD | -7.62% |
| 1996 | -11.1 Million USD | -26.51% |
| 1995 | -10.2 Million USD | -20.29% |
| 1994 | -7.6 Million USD | -21.05% |
| 1993 | -6.2 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 52 Million USD | 91.33% |
| 2024 Q2 | 58.8 Million USD | 1056.17% |
| 2024 Q3 | 73.44 Million USD | 48.63% |
| 2023 Q2 | 32.2 Million USD | 153.54% |
| 2023 Q3 | 19.6 Million USD | -39.13% |
| 2023 FY | - USD | 44.62% |
| 2023 Q4 | -88 Million USD | -548.98% |
| 2023 Q1 | 12.7 Million USD | -56.41% |
| 2022 FY | - USD | 64.93% |
| 2022 Q4 | 29.13 Million USD | 159.64% |
| 2022 Q3 | 11.22 Million USD | -64.71% |
| 2022 Q2 | 31.8 Million USD | 31.14% |
| 2022 Q1 | 24.24 Million USD | -2.22% |
| 2021 Q1 | 23.43 Million USD | 196.44% |
| 2021 Q2 | -18.28 Million USD | -178.01% |
| 2021 Q3 | -26.11 Million USD | -42.85% |
| 2021 Q4 | 24.8 Million USD | 194.96% |
| 2021 FY | - USD | 74.03% |
| 2020 Q3 | 18.08 Million USD | 59.25% |
| 2020 FY | - USD | -70.61% |
| 2020 Q2 | 11.35 Million USD | -50.18% |
| 2020 Q1 | 22.8 Million USD | -52.6% |
| 2020 Q4 | -24.3 Million USD | -234.34% |
| 2019 Q1 | 2.11 Million USD | -95.91% |
| 2019 Q2 | 49.65 Million USD | 2245.54% |
| 2019 Q4 | 48.1 Million USD | 128.04% |
| 2019 Q3 | 21.09 Million USD | -57.52% |
| 2019 FY | - USD | -16.13% |
| 2018 Q1 | 34.6 Million USD | -8.71% |
| 2018 Q3 | 25.32 Million USD | -43.36% |
| 2018 Q4 | 51.8 Million USD | 104.58% |
| 2018 Q2 | 44.7 Million USD | 29.19% |
| 2018 FY | - USD | -26.08% |
| 2017 Q4 | 37.9 Million USD | -33.86% |
| 2017 FY | - USD | -13.33% |
| 2017 Q3 | 57.3 Million USD | 0.75% |
| 2017 Q2 | 56.87 Million USD | 10.57% |
| 2017 Q1 | 51.43 Million USD | 12.8% |
| 2016 Q4 | 45.6 Million USD | -24.48% |
| 2016 Q3 | 60.38 Million USD | 16.57% |
| 2016 FY | - USD | 115.2% |
| 2016 Q2 | 51.8 Million USD | 116.74% |
| 2016 Q1 | 23.9 Million USD | 0.0% |
| 2015 Q3 | 31.53 Million USD | -12.04% |
| 2015 FY | - USD | 21.89% |
| 2015 Q2 | 35.85 Million USD | 1.19% |
| 2015 Q1 | 35.43 Million USD | 49.73% |
| 2014 Q1 | 24.81 Million USD | 9.99% |
| 2014 Q2 | 23.56 Million USD | -5.06% |
| 2014 Q4 | 23.66 Million USD | -14.6% |
| 2014 Q3 | 27.71 Million USD | 17.6% |
| 2014 FY | - USD | 16.13% |
| 2013 Q3 | 23.24 Million USD | 4.15% |
| 2013 Q4 | 22.56 Million USD | -2.91% |
| 2013 Q1 | 20.37 Million USD | -5.09% |
| 2013 FY | - USD | 30.62% |
| 2013 Q2 | 22.31 Million USD | 9.51% |
| 2012 Q3 | 21.38 Million USD | 16.22% |
| 2012 Q1 | 20.26 Million USD | 16.35% |
| 2012 FY | - USD | 23.9% |
| 2012 Q4 | 21.46 Million USD | 0.42% |
| 2012 Q2 | 18.39 Million USD | -9.2% |
| 2011 Q3 | 15.14 Million USD | 22.78% |
| 2011 FY | - USD | 33.81% |
| 2011 Q4 | 17.41 Million USD | 14.97% |
| 2011 Q2 | 12.33 Million USD | -10.78% |
| 2011 Q1 | 13.82 Million USD | 10.54% |
| 2010 Q2 | 11.7 Million USD | -9.14% |
| 2010 Q1 | 12.88 Million USD | 42.36% |
| 2010 FY | - USD | 64.94% |
| 2010 Q3 | 13.57 Million USD | 16.02% |
| 2010 Q4 | 12.5 Million USD | -7.89% |
| 2009 Q1 | 6.79 Million USD | -38.24% |
| 2009 Q4 | 9.04 Million USD | -4.15% |
| 2009 FY | - USD | 678.62% |
| 2009 Q3 | 9.43 Million USD | 44.02% |
| 2009 Q2 | 6.55 Million USD | -3.58% |
| 2008 FY | - USD | 91.34% |
| 2008 Q2 | 3.61 Million USD | -6.31% |
| 2008 Q4 | 11 Million USD | 2482.54% |
| 2008 Q1 | 3.85 Million USD | 133.91% |
| 2008 Q3 | 426.2 Thousand USD | -88.21% |
| 2007 Q2 | -6.88 Million USD | 23.38% |
| 2007 Q1 | -8.98 Million USD | 47.93% |
| 2007 Q3 | -2.49 Million USD | 63.84% |
| 2007 Q4 | 1.64 Million USD | 166.21% |
| 2007 FY | - USD | 18.41% |
| 2006 Q1 | -2.83 Million USD | 78.65% |
| 2006 Q4 | -17.26 Million USD | -55.29% |
| 2006 Q3 | -11.11 Million USD | -51.17% |
| 2006 FY | - USD | -508.82% |
| 2006 Q2 | -7.35 Million USD | -159.2% |
| 2005 FY | - USD | -180.23% |
| 2005 Q4 | -13.28 Million USD | 36.29% |
| 2005 Q3 | -20.85 Million USD | -16.95% |
| 2005 Q2 | -17.83 Million USD | -203.72% |
| 2005 Q1 | -5.87 Million USD | -3346.24% |
| 2004 Q1 | 652.49 Thousand USD | -97.27% |
| 2004 Q2 | -1.93 Million USD | -396.98% |
| 2004 Q3 | -1.02 Million USD | 47.18% |
| 2004 FY | - USD | 21.57% |
| 2004 Q4 | -170.37 Thousand USD | 83.35% |
| 2003 Q2 | 3.87 Million USD | -28.64% |
| 2003 Q4 | 24.28 Million USD | 384.47% |
| 2003 FY | - USD | 140.11% |
| 2003 Q1 | 5.33 Million USD | 13.63% |
| 2003 Q3 | 5.1 Million USD | 31.01% |
| 2002 Q3 | 2.39 Million USD | 178.55% |
| 2002 Q4 | 4.89 Million USD | 87.12% |
| 2002 FY | - USD | 0.0% |
| 2002 Q2 | -2.81 Million USD | 47.07% |
| 2002 Q1 | -5.88 Million USD | -26.14% |
| 2001 Q3 | -6.1 Million USD | 0.71% |
| 2001 Q2 | -6.17 Million USD | -153.41% |
| 2001 Q4 | -4.76 Million USD | 23.05% |
| 2001 Q1 | -2.47 Million USD | 26.55% |
| 2000 Q2 | -2.01 Million USD | -2552.29% |
| 2000 Q1 | 62.74 Thousand USD | 141.44% |
| 2000 FY | - USD | 70.42% |
| 2000 Q4 | -11.22 Million USD | -182.62% |
| 2000 Q3 | -883.46 Thousand USD | 297.91% |
| 1999 Q2 | -400 Thousand USD | 128.13% |
| 1999 Q1 | -3.03 Million USD | 30.43% |
| 1999 Q3 | -1.6 Million USD | -277.78% |
| 1999 Q4 | -200 Thousand USD | 87.5% |
| 1999 FY | - USD | 27.43% |
| 1998 FY | - USD | -54.87% |
| 1998 Q4 | -4 Million USD | 22.03% |
| 1998 Q3 | -5.2 Million USD | 0.0% |
| 1998 Q2 | -5.2 Million USD | -118.52% |
| 1998 Q1 | -2.7 Million USD | 22.86% |
| 1997 Q1 | -3.1 Million USD | -19.23% |
| 1997 FY | - USD | -7.62% |
| 1997 Q4 | -2.9 Million USD | 35.19% |
| 1997 Q3 | -5.4 Million USD | -68.75% |
| 1997 Q2 | -3.3 Million USD | -3.23% |
| 1996 Q1 | -2.5 Million USD | 3.85% |
| 1996 Q2 | -3.1 Million USD | -24.0% |
| 1996 Q3 | -2.1 Million USD | 32.26% |
| 1996 Q4 | -2.6 Million USD | -23.81% |
| 1996 FY | - USD | -26.51% |
| 1995 Q4 | -2.5 Million USD | -8.33% |
| 1995 Q1 | -1.7 Million USD | 0.0% |
| 1995 FY | - USD | -20.29% |
| 1995 Q3 | -2.2 Million USD | 11.11% |
| 1995 Q2 | -2.5 Million USD | -42.11% |
| 1994 Q4 | -1.9 Million USD | -5.56% |
| 1994 FY | - USD | -21.05% |
| 1994 Q1 | -1.4 Million USD | 11.11% |
| 1994 Q2 | -1.3 Million USD | 6.25% |
| 1994 Q3 | -1.7 Million USD | -20.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q1 | -1 Million USD | 0.0% |
| 1993 Q4 | -1.8 Million USD | 0.0% |
| 1993 Q2 | -1.9 Million USD | -72.73% |
| 1993 Q3 | -1.6 Million USD | 5.26% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 389.286% |
| Cerus Corporation | -26.53 Million USD | 247.03% |
| OrthoPediatrics Corp. | -8.38 Million USD | 565.529% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 471.776% |
| Talis Biomedical Corporation | -66.04 Million USD | 159.075% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 333.979% |
| Inogen, Inc. | -45.67 Million USD | 185.413% |
| Spectral AI, Inc. | -12.26 Million USD | 418.186% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 181.807% |
| CVRx, Inc. | -38.73 Million USD | 200.736% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 1205.896% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 422.26% |
| Orthofix Medical Inc. | -86.98 Million USD | 144.854% |
| Venus Concept Inc. | -26.11 Million USD | 249.412% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 178.391% |
| Bioventus Inc. | -23.07 Million USD | 269.12% |
| BrainsWay Ltd. | -2.31 Million USD | 1788.273% |
| Envoy Medical, Inc. | -18.23 Million USD | 313.927% |
| electroCore, Inc. | -17.76 Million USD | 319.685% |
| IceCure Medical Ltd | -15.25 Million USD | 355.792% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 178.423% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 331.471% |
| MaxCyte, Inc. | -44.12 Million USD | 188.416% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 431.882% |
| Nexalin Technology, Inc. | -5.69 Million USD | 785.448% |
| PAVmed Inc | -75.74 Million USD | 151.512% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 172.577% |
| RxSight, Inc. | -41.03 Million USD | 195.075% |
| Sight Sciences, Inc. | -49.41 Million USD | 178.956% |
| SI-BONE, Inc. | -34.44 Million USD | 213.267% |
| TELA Bio, Inc. | -40.63 Million USD | 196.02% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 166.925% |
| Treace Medical Concepts, Inc. | -39 Million USD | 200.021% |
| 908 Devices Inc. | -34.02 Million USD | 214.669% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 135.279% |
| Nemaura Medical Inc. | -7.28 Million USD | 635.415% |
| NeuroPace, Inc. | -22.83 Million USD | 270.868% |
| LENSAR, Inc. | -8.71 Million USD | 547.739% |
| Apyx Medical Corporation | -18.11 Million USD | 315.415% |
| Cutera, Inc. | -136.56 Million USD | 128.57% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 1254.32% |
| BioSig Technologies, Inc. | -28.15 Million USD | 238.595% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -1450.715% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 285.888% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 89.828% |
| Axonics, Inc. | 7.77 Million USD | -401.814% |
| Outset Medical, Inc. | -153.78 Million USD | 125.37% |
| IRIDEX Corporation | -7.44 Million USD | 623.845% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 139.774% |
| IRadimed Corporation | 20.8 Million USD | -87.571% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 583.949% |
| INVO Bioscience, Inc. | -6.88 Million USD | 667.091% |
| Telesis Bio, Inc. | -40.49 Million USD | 196.352% |
| Viemed Healthcare, Inc. | 36.67 Million USD | -6.377% |
| Varex Imaging Corporation | 67.2 Million USD | 41.94% |
| Quipt Home Medical Corp. | 44.07 Million USD | 11.47% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 458.933% |
| Pulmonx Corporation | -55.09 Million USD | 170.82% |
| Dynatronics Corporation | -976 Thousand USD | 4097.508% |
| Modular Medical, Inc. | -17.1 Million USD | 328.124% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 369.355% |
| Semler Scientific, Inc. | 23.58 Million USD | -65.399% |
| InMode Ltd. | 196.28 Million USD | 80.123% |
| Bruker Corporation | 599 Million USD | 93.486% |
| Cytosorbents Corporation | -28.81 Million USD | 235.421% |
| DexCom, Inc. | 916.7 Million USD | 95.744% |
| Align Technology, Inc. | 799.03 Million USD | 95.117% |
| Viveve Medical, Inc. | -20.61 Million USD | 289.242% |
| ZimVie Inc. | 91.07 Million USD | 57.16% |
| Movano Inc. | -29.12 Million USD | 233.961% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 985.118% |
| Nexalin Technology, Inc. | -5.69 Million USD | 785.448% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 1205.896% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 120.043% |
| Profound Medical Corp. | -27.12 Million USD | 243.846% |
| Insulet Corporation | 323.6 Million USD | 87.943% |
| enVVeno Medical Corporation | -25.01 Million USD | 255.952% |
| Surmodics, Inc. | 1.18 Million USD | -3184.175% |
| iCAD, Inc. | -6.56 Million USD | 694.303% |
| Nuwellis, Inc. | -16.35 Million USD | 338.542% |
| Biotricity, Inc. | -8.82 Million USD | 541.944% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 140.28% |
| Aethlon Medical, Inc. | -11.84 Million USD | 429.273% |
| InspireMD, Inc. | -20.91 Million USD | 286.581% |
| PAVmed Inc. | -75.74 Million USD | 151.512% |
| BIOLASE, Inc. | -15.13 Million USD | 357.718% |
| Beyond Air, Inc. | -59.03 Million USD | 166.094% |
| FONAR Corporation | 28.25 Million USD | -38.102% |
| AxoGen, Inc. | -13.32 Million USD | 392.737% |
| Vivani Medical, Inc. | -26.6 Million USD | 246.633% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | -58.983% |
| Inari Medical, Inc. | 7.11 Million USD | -448.517% |
| UFP Technologies, Inc. | 72.74 Million USD | 46.365% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 1252.347% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 733.789% |
| Tenon Medical, Inc. | -15.52 Million USD | 351.262% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 355.574% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 194.069% |
| AdaptHealth Corp. | -171.09 Million USD | 122.804% |
| Sintx Technologies, Inc. | -6.6 Million USD | 691.152% |
| NanoVibronix, Inc. | -3.43 Million USD | 1235.837% |
| Quanterix Corporation | -38.08 Million USD | 202.436% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 458.933% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -129953.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 114.071% |
| TransMedics Group, Inc. | -7.6 Million USD | 613.166% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 279.26% |
| NeuroMetrix, Inc. | -7.09 Million USD | 649.846% |
| Hyperfine, Inc. | -47.06 Million USD | 182.905% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 166.915% |
| Biomerica, Inc. | -5.99 Million USD | 751.026% |
| Bone Biologics Corporation | 479.57 Thousand USD | -8035.588% |
| AVITA Medical, Inc. | -39.56 Million USD | 198.606% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 525.338% |
| Silk Road Medical, Inc | -45.08 Million USD | 186.548% |